MolNFT v1 · #151278 · protein
Crystal structure of hpxr in complex with dabrafenib
6HJ2 · Nuclear receptor subfamily 1 group I member 2: “Crystal structure of hpxr in complex with dabrafenib”. X-ray diffraction, 1 ligand (P06), 3 pockets (best druggability 0.85). MolNFT v1 #151278 on GenesisL1: 3D structure, binding…
- PDB
- 6HJ2
- Type
- protein
- Length
- 274 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Nuclear receptor subfamily 1 group I member 2
- UniProt
- O75469
- Ligands
- P06
- Pockets
- 3 · best druggability 0.85
Structure
x-ray diffraction · 1 distinct chain · 59% helix, 8% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Nuclear receptor subfamily 1 group I member 2 | protein | 274 | 59% helix, 8% strand | O75469 |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 472 | 0.85 | 0.91 | 43 | P06 |
| 2 | 74 | 0.32 | 0.74 | 17 | empty |
| 3 | 50 | 0.31 | 0.77 | 11 | empty |
Compared structures
- 6HJ2 · Crystal structure of hPXR in complex with dabrafenib · the same entry in another collection · chain A against A, TM-score 1.00
- O75469 · AlphaFold monomer V2.0 prediction for nuclear receptor subfamily 1 group I member 2… · a predicted model of the same protein · chain A against A, TM-score 0.98
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O75469
- Elsewhere: RCSB PDB 6HJ2 · PDBe 6HJ2 · UniProt O75469
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.